NCT05355818 - Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 14, 2022

Primary Completion Date

December 5, 2024

Study Completion Date

December 17, 2024

Conditions

Chronic Hand Eczema

Interventions

DRUG

Delgocitinib

Cream for topical application

DRUG

Cream vehicle

The cream vehicle is similar to the delgocitinib cream except that it does not contain any active medical ingredient.

Trial Locations (37)

1200

LEO Pharma investigational site, Brussels

2010

LEO Pharma investigational site, Darlinghurst

2606

LEO Pharma investigational site, Phillip

3132

LEO Pharma investigational site, Mitcham

4000

LEO Pharma investigational site, Liège

4102

LEO Pharma investigational site, Woolloongabba

6060

LEO Pharma investigational site, Gilly

9000

LEO Pharma investigational site, Ghent

11009

LEO Pharma investigational site, Cadiz

13500

LEO Pharma investigational site, Martigues

18016

LEO Pharma investigational site, Granada

28942

LEO Pharma investigational site, Fuenlabrada

31059

LEO Pharma investigational site, Toulouse

51100

LEO Pharma investigational site, Reims

T6G 1C3

LEO Pharma investigational site, Edmonton

E3B 1G9

LEO Pharma investigational site, Fredericton

K7L 2V7

LEO Pharma investigational site, Kingston

H3T 1C5

LEO Pharma investigational site, Montreal

T4P1K4

LEO Pharma investigational site, Red Deer

NL A1E 1V4

LEO Pharma investigational site, St. John's

M2N 3A6

LEO Pharma investigational site, Toronto

R3C 0N2

LEO Pharma investigational site, Winnipeg

06000

LEO Pharma investigational site, Nice

41-516

LEO Pharma investigational site, Chorzów

30-002

LEO Pharma investigational site, Krakow

30-033

LEO Pharma investigational site, Krakow

31-011

LEO Pharma investigational site, Krakow

02-625

LEO Pharma investigational site, Warsaw

51-503

LEO Pharma investigational site, Wroclaw

03010

LEO Pharma investigational site, Alicante

08041

LEO Pharma investigational site, Barcelona

08950

LEO Pharma investigational site, Esplugues de Llobregat

IP4 5PD

LEO Pharma investigational site, Ipswich

PE30 4ET

LEO Pharma investigational site, Kings Lynn

LN2 5QY

LEO Pharma investigational site, Lincoln

SW10 9NH

LEO Pharma investigational site, London

WS2 9PS

LEO Pharma investigational site, Walsall